Abstract C081: Discovery and characterization of AKT1-E17K mutant-selective inhibitors for the treatment of AKT1-E17K mutant cancers
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Tine Wyseure, Noah Ibrahim, Zoe Rush, Sarah Jacinto, Joseph McLaughlin, John Sigler, Alanna Sedgwick, Rediet Zewdu, Albert Parker, Sarah Ur, Marie Pariollaud, Dylan Nelson, Tomas Vilimas, Debarati Mukherjee, Betty Lam, Fabian Goericke, Blake Houser, Jonathan Pollock, Benjamin Horning, Nil Roy, Shota Kikuchi, Brian Cook, Gabe Simon, David Weinstein, Todd Kinsella, Matt Patricelli
Institution: Vividion Therapeutics (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4415444864
Cites:
Cited by:
Related to: